Status:
COMPLETED
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
This study was designed to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray and commonly used drug in the treatment of seasonal allergic rhinitis. Al...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Informed consent
- Outpatient
- Diagnosis of seasonal allergic rhinitis with symptoms
- Able to comply with study procedures
- Exclusion Criteria:
- Significant concomitant medical condition
- Use of corticosteroids/allergy medications
- Laboratory abnormality
- Positive pregnancy test
- Allergy to any component of investigational product
Exclusion
Key Trial Info
Start Date :
February 19 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2005
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00363740
Start Date
February 19 2005
End Date
April 13 2005
Last Update
August 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site